Radionuclide Therapy

Which of the following property of radiation is principally used in the treatment of tumors?

Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is:

All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding:

According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range:

Which of the following time is advised for patients treated with 1-131 to delay conception after treatment?

Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy?

Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called:

The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT:

The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called:

The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: